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ABSTRACT
Cutaneous neurogenic inﬂammation (CNI) is inﬂamma-
tion that is induced (or enhanced) in the skin by the
release of neuropeptides from sensory nerve endings.
Clinical manifestations are mainly sensory and vascular
disorders such as pruritus and erythema. Transient
receptor potential vanilloid 1 and ankyrin 1 (TRPV1 and
TRPA1, respectively) are non-selective cation channels
known to speciﬁcally participate in pain and CNI. Both
TRPV1 and TRPA1 are co-expressed in a large subset of
sensory nerves, where they integrate numerous noxious
stimuli. It is now clear that the expression of both
channels also extends far beyond the sensory nerves in
the skin, occuring also in keratinocytes, mast cells,
dendritic cells, and endothelial cells. In these non-neu-
ronal cells, TRPV1 and TRPA1 also act as nociceptive
sensors and potentiate the inﬂammatory process. This
review discusses the role of TRPV1 and TRPA1 in the
modulation of inﬂammatory genes that leads to or
maintains CNI in sensory neurons and non-neuronal
skin cells. In addition, this review provides a summary of
current research on the intracellular sensitization path-
ways of both TRP channels by other endogenous
inﬂammatory mediators that promote the self-mainte-
nance of CNI.
KEYWORDS sensory nerve, neurogenic skin
inﬂammation, inﬂammatory gene regulation, pruritus
INTRODUCTION
CNI deﬁnition, induction, and self-maintenance
Cutaneous neurogenic inﬂammation (CNI) is the inﬂamma-
tion induced (or enhanced) by an excessive release of
neuropeptides such as calcitonin gene-related peptide
(CGRP) and tachykinins (mainly substance P, SP) in the skin
from locally or antidromically activated sensory nerve end-
ings (Herbert and Holzer, 2002; Roosterman et al., 2006;
Gouin et al., 2015).
CNI can be induced through the direct activation of
receptors on sensory nerve endings by mechanical skin
injuries and other exogenous stimuli, such as exposure of the
skin to injurious heat or cold, ultraviolet (physical factors),
chemical irritants or allergens. Endogenous stimuli, including
osmotic or pH changes in the skin, can also initiate CNI
(Herbert and Holzer, 2002; Roosterman et al., 2006). The
released neuropeptides act on skin cells that express cog-
nate neuropeptide receptors, including microvascular cells
and resident mast cells, leading to degranulation, vasodila-
tion, and extravasation of plasma proteins and leukocytes.
Some clinical manifestations of acute CNI are localized pru-
ritus, redness, heat, and edema (Herbert and Holzer 2002;
Roosterman et al., 2006; Teresiak-Mikołajczak et al., 2013).
Moreover, neuropeptides and mast cell-released media-
tors can act on other neighboring target cells, including
keratinocytes, dendritic cells, neutrophils and ﬁbroblasts,
leading to the disruption of skin homeostasis, with abnormal
skin growth, differentiation, and/or immunomodulation (Shim











et al., 2007; Trevisani et al., 2007; Wilson et al., 2013b;
Patricio et al., 2015).
Furthermore, a variety of neurotrophic (e.g. nerve growth
factor, NGF) or inﬂammatory mediators (e.g. proteases, his-
tamine, cytokines, prostanoids) or endocannabinoids (e.g.
anandamide) released by skin cells/nerve ﬁbers or chemoat-
tracted cells are able to further activate or sensitize these
sensory receptors (Briot et al., 2009; Vellani et al., 2010;
Roostermanet al., 2006;Riol-Blancoet al., 2014;Wilsonet al.,
2013b; Wei et al., 2012). Such positive feedback loops con-
tribute to the enhancement of the inﬂammatory process and
thus to self-maintained CNI (Gouin et al., 2015).
Therefore, CNI appears to be a multi-cellular network with
multiple, multi-directional interactions leading to a vicious
circle of processes that results in chronic inﬂammation
(Gouin et al., 2015). Indeed, CNI is frequently involved in
chronic inﬂammatory skin disorders, including psoriasis,
atopic dermatitis (AD) (Kubanov et al., 2015; Smolyannikova
et al., 2015), sensitive skin (Costa et al., 2014), rosacea
(Kürkçüoğlu and Alaybeyi 1991; Salem et al., 2013), and
hypertrophic scars (Akaishi et al., 2008; Kwak et al., 2014).
Role of PARs and TRPs
Although the exocytosis of neuropeptides from large dense-
core vesicles differs from that of classical neurotransmitters
from small clear vesicles, it is also triggered by a rise in the
cytosolic Ca2+ concentration (Huang and Neher 1996;
Zupanc 1996; Jans et al., 2004). Two primary pathways lead
to increased Ca2+ concentration in the cytosol, the Ca2+
inﬂux associated with the opening of plasmalemmal Ca2+
channels and the Ca2+ released from intracellular stores (the
endoplasmic reticulum and mitochondria). In addition to
voltage-gated Ca2+ channels, cutaneous sensory nerves
express cationic channels and G protein-coupled receptors
(GPCRs), the activation of which can lead directly or indi-
rectly to an increase in cytosolic Ca2+. In addition to the
induction of neuropeptide release, an increase in cytosolic
Ca2+ can also drive the regulation of the expression of
several inﬂammatory genes, such as those encoding neu-
ropeptides, cytokines, growth factors, prostaglandins (PG),
and matrix metalloproteinases (MMPs), which have a pos-
sible role in chronic cutaneous inﬂammation.
Interestingly, cationic channels expressed by cutaneous
nerveendings include some transient receptor potential (TRP)
channels known to be involved in neuropeptide exocytosis
and skin disorders that have neurogenic mechanisms. In this
review we focus on two of these channels including TRPV1
and TRPA1 (TRP subfamily vanilloid 1 and TRP subfamily
ankyrin 1, respectively) (Xie 2009; Wei et al., 2010; Boillat
et al., 2014; Horváth et al., 2015). Other TRP channels have
also been found to be involved in CNI and pruritus such as
TRPV3 (Lin et al., 2012) and TRPV4 (Zhao et al., 2014;
Rajasekhar et al., 2015;Akiyamaet al., 2016;Kimet al., 2016).
In addition, the sensory nerves in the skin also express
GPCRs, of which the protease-activated receptor (PAR)
family in particular is known to be involved in CNI, especially
PAR-2 and PAR-4 (Cocks and Moffatt 2000). Thus, TRPV1,
TRPA1, PAR-2, and PAR-4 are associated not only with a rise
in the intracellular Ca2+ concentration (iCa2+) with the subse-
quent exocytosis of neuropeptides but also with pro-inﬂam-
matory gene expression (Fig. 1). Moreover, following the
activation of oneof these receptors, intracellular pathways can
lead to the sensitization of one of these channels.
In addition to their expression by sensory nerves, TRPV1,
TRPA1, PAR-2, and PAR-4 are found in resident skin cells or
cells recruited during CNI. Thus, they could contribute to the
intense and narrow communication within the skin between
sensory nerve endings, skin, and immune cells.
This review discusses the role of TRPV1 and TRPA1
activation or signaling pathways associated with their sen-
sitization in the self-maintenance of CNI through the induc-
tion of a pro-inﬂammatory response in the skin.
TRPV1
A cationic channel with multiple direct roles in CNI
induction and self-maintenance
TRPV1 is a nociceptive cationic (mainly Ca2+) channel
responsive tohigh temperature (>43°C) (Boillat et al., 2014). In
addition to excessive heat, various exogenous and endoge-
nous triggering factors can directly activate or sensitize
TRPV1 (Table 1). TRPV1 was initially described in cutaneous
C- andAδ-type sensory nerve endings, where it plays a critical
role. It can be activated by the natural agonist capsaicin
(Jancsó et al., 1967; Caterina et al., 1997). High temperature
and capsaicin have been demonstrated to activate sensory
nerves and induce neurogenic inﬂammation (Jancsó et al.,
1967; Caterina et al., 1997). Indeed, TRPV1 activation by
these direct activators allows the entry of Ca2+, leading to the
release of neuropeptides, including SP (Andreev et al., 2012)
and CGRP (Boillat et al., 2014), that control edema and can
induce (or enhance) neurogenic inﬂammation (Szallasi and
Blumberg 1989; Zygmunt et al., 1999; Steinhoff et al., 2003;
Roosterman et al., 2006; Vincent et al., 2013).
Furthermore, endogenousmediators produced or released
duringCNI (eicosanoids, acidosis, ATP, histamine, bradykinin,
NGF) that further sensitize or activate TRPV1 on skin
nerve terminals contribute to the self-maintenance of CNI
(Roosterman et al., 2006). Moreover, TRPV1 was found to be
expressed in skin cells (keratinocytes, dermal mast cells,
dendritic cells, sebocytes, dermal blood vessels, hair follicles,
and sweat glands), where it acts as a pain and chemical
sensor (Ständer et al., 2004).
TRPV1 sensitization/desensitization by endogenous
modulators following intracellular pathway activation
Intracellular pathways of TRPV1 sensitization
The TRPV1 sensitization process is an intracellular mecha-
nism that facilitates the gating of the channel or strengthens
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the currents evoked during the subsequent activation of
TRPV1. The structure of TRPV1 was obtained by high-res-
olution cryo-electron microscopy (cryo-EM) and revealed
multiple intracellular regulatory domains (Liao et al., 2013).
TRPV1 is a polymodal receptor whose sensitization and
endogenous regulatory pathways act via phosphorylation
sites for kinases such as protein kinases C and A (PKC and
PKA) and Ca2+/calmodulin dependent kinase II (CAMKII).
PKC phosphorylates and sensitizes TRPV1 at the S502 and
S800 phosphorylation sites (Numazaki et al., 2002; Bhave
et al., 2003). The PKA phosphorylation sites S116, T370,
S502, and T144 appear to sensitize TRPV1 and prevent its
desensitization upon the repeated application of capsaicin
(Bhave et al., 2002; Mohapatra and Nau 2003; Mohapatra
and Nau 2005; Amadesi et al., 2006). Several studies have
identiﬁed two speciﬁc phosphorylation sites for CAMKII on
TRPV1 (S502 and T704) that modulate vanilloid binding.
Thus, in human embryonic kidney-derived (HEK293) cells
expressing Δ774–838-deleted CaMKII phosphorylation sites
(Woo et al., 2008) or S502A/T704I mutants of TRPV1,
capsaicin does not evoke a current, which suggests that
phosphorylation by CaMKII is required to control the
responsiveness of TRPV1 to the ligand (Jung et al., 2004).
Phospholipase C (PLC) activity goes through the
decrease of phosphatidylinositol 4,5-bisphosphate (PIP2)
level and through the production of diacylglycerol (DAG),
both of which are involved in TRPV1 sensitization. Indeed,
the correlation between PIP2 and the intracellular sensiti-
zation of TRPV1 has been established; both bradykinin and
NGF (known to stimulate PLC pathways after binding to their
cognate receptors) potentiated TRPV1 activity in a heterol-
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Figure 1. Common intracellular GPCR, RTK and Ca2+ pathways regulate via the activation and sensitization of TRPV1 and
TRPA1. The G protein-coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activation stimulate phospholipase C (PLC),
which leads to phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis and the consequent release of the transient receptor potential
(TRP) channels from its inhibitory control, triggering the formation of 1,4,5-trisphosphate (IP3) and diaglycerol (DAG) as well as the
inﬂux of Ca2+ via TRP vanilloid 1 and ankyrin 1 (TRPV1 and TRPA1). Then, DAG can directly activate both TRP channels, and protein
kinase C (PKC) activation by DAG enhances TRP activity, sensitizing both channels. IP3 formation promotes Ca2+ release from the
endoplasmic reticulum and increases the iCa2+ concentration. GPCRs can also activate the phospholipase A2 (PLA2) and adenylate
cyclase pathways, which lead to protein kinase A (PKA) stimulation and the formation of arachidonic acid (AA) metabolites and
products. PKA acts directly sensitize the TRP channels, while AA metabolites and products directly activate the TRP channels. Both
TRPV1 and TRPV1 can directly or indirectly regulate the activity of the other by direct interaction or via the iCa2+ concentration,
resulting in a cross-sensitization/desensitization process. The elevation of iCa2+ triggers the exocytosis of inﬂammatory mediators
and stimulates both Ca2+/calmodulin-dependent kinase II (CAMKII) and calcineurin, which sensitize and desensitize TRPV1,
respectively. Both kinases are also involved in the regulation of inﬂammatory genes via nuclear factor of activated T-cell (NFAT)
translocation to the nucleus.
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Table 1. Endogenous and exogenous agonists involved in TRPV1 activation, sensitization, and inhibition
Factors Pathways of activation References
Exogenous activators of TRPV1a:
High temperature (>43°C)






(Boillat et al., 2014)
(Caterina et al., 1997)
(Tominaga et al., 1998)








(Caterina et al., 1997)
(Szallasi and Blumberg 1989)






(Smart et al., 2000)








(Huang et al., 2002)





(Jung et al., 2004)
(Woo et al., 2008)
PIP2j Binding the extracellular leaﬂet (site: 777–820) (Senning et al., 2014)
(Ufret-Vincenty et al., 2015)
Indirect activators/sensitizers of TRPV1:
Bradykinin





(Chuang et al., 2001)
(Vellani et al., 2001)
(Zhang et al., 2008)
Proteases PAR-2 and PAR-4t (GPCR) (Amadesi et al., 2004, 2006)
(Vellani et al., 2010)
Serotonin 5-HTRu (GPCR) (Sugiura et al., 2002)
Histamine H1R and H4Rv (GPCR) (Jian et al., 2016)
(Shim et al., 2007)
ATPm P2Y1Rw (GPCR) (Numazaki et al., 2002)
(Tominaga et al., 2001)
TRPA1n Physical interaction or
Ca2+ second messenger
(Anand et al., 2008)
(Alpizar et al., 2013)
(Spahn et al., 2014)
DAG Indirectly by PKCx activation (Burgess et al., 1989)
(Chuang et al., 2001)
(Cesare et al., 1999)
Inhibitors/desensitizers of TRPV1:
Calcineurino iCa2+-dependent dephosphorylation of TRPV1 (Docherty et al., 1996)
(Jeske et al., 2006)
(Patwardhan et al., 2006)
PIP2 Binding the intracellular leaﬂet (site: 777–820) (Senning et al., 2014)
(Ufret-Vincenty et al., 2015)
(Woo et al., 2008)
(Chuang et al., 2001)
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neurons (Chuang et al., 2001). The role of PIP2 as a TRPV1
inhibitor or “desensitizer” after its depletion by sequestration
or PLC hydrolysis has been subsequently shown to be
essential for TRPV1 sensitization (Prescott and Julius 2003).
In addition, the lack of a PIP2 binding site (786–828)
increased the strong inward current evoked by a DAG ana-
log and capsaicin in a Δ774–838 deletion mutant of TRPV1
(Woo et al., 2008). However, PIP2 could activate TRPV1 by
binding the extracellular leaﬂet (777–820), while it has an
inhibitor effect by binding the intracellular leaﬂet (682–725)
(Senning et al., 2014; Ufret-Vincenty et al., 2015). Interest-
ingly, in addition to its ability to directly activate TRPV1 via a
PKC-independent pathway by binding to the capsaicin
binding site at Y511; (Woo et al., 2008)), DAG could also
contribute to the indirect sensitization of TRPV1 via PKC
phosphorylation at the S502 and S801 sites (Burgess et al.,
1989; Cesare et al., 1999; Chuang et al., 2001) (Numazaki
et al., 2002; Bhave et al., 2003).
Finally, it might be noticed that the prolonged or repeated
activation of TRPV1 induces a desensitization or inhibition
process. It has been observed that the repeated activation of
TRPV1 by chemical stimuli results in its desensitization by a
Ca2+-dependent process (Chuang et al., 2001; Bhave et al.,
2002; Dai et al., 2004). Protein phosphatase 2B (calcineurin)
acts as a desensitizer of TRPV1, as indicated by the inhi-
bition of calcineurin by cyclosporine or CsA-CyP, which have
been shown to inhibit the desensitization of TRPV1 induced
by capsaicin (Docherty et al., 1996; Mohapatra and Nau
2005). The cannabinoid WIN 55,212-2 seems to play an anti-
inﬂammatory and analgesic role via the inhibition of TRPV1
by dephosphorylating the T144 and T370 sites in a Ca2+/
calcineurin-dependent manner, reducing the release of
CGRP (Patwardhan et al., 2006; Jeske et al., 2006). These
data show the potential effects of calcineurin inhibitors on
TRPV1 desensitization and suggest cannabinoids as new
therapeutic drugs for CNI, hyperalgesia, itching, and pain.
Inﬂammatory mediators that use TRPV1 intracellular
sensitization pathways
Following tissue damage, endogenously released inﬂam-
matory mediators (ATP, bradykinin, serotonin PGs, NGF,
chemokines, histamine or proteases) can regulate TRPV1
activity via intracellular pathways associated with their
speciﬁc GPCR. For example, in transfected HEK293 cells
and DRG neurons, ATP increased capsaicin-induced
TRPV1 activation via the purinergic receptor P2Y1, which
potentiated TRPV1 activity in a PKC-dependent pathway
(Tominaga et al., 2001; Numazaki et al., 2002). In the same
way, in a Ca2+- and PLC/PKC-dependent manner, bradyki-
nin, serotonin (G protein-coupled 5-HT receptor), PgE2 (G
protein-coupled EP receptors), and NGF enhanced cap-
saicin-, heat-, proton-, and anandamine-evoked currents
(Vellani et al., 2001; Sugiura et al., 2002; Zhang et al., 2008;
Wilson et al., 2011). Similarly, the chemokine CCL3 was
found to sensitize TRPV1 by increasing the heat-, anan-
damide-, and capsaicin-evoked Ca2+ inﬂux through a PLC-
and PKC-pathway in HEK293 cells and DRG neurons
(Zhang et al., 2005).
Finally, histamine enhanced the capsaicin-mediated
inward current, increased the Ca2+ level and then induced
itching via sensory neurons, and this effect was abolished by
TRPV1 antagonists and in TRPV1-deﬁcient mice (Shim
et al., 2007). These mechanisms appeared to involve
phospholipase A2 (PLA2)-, lipoxygenase (NDGA)- and PLC-
dependent pathways, with the subsequent sensitization and
activation of TRPV1 (Jian et al., 2016). These studies sug-
gest that TRPV1 is involved in histamine-dependent itching
with arachidonic acid metabolites, primarily 12-hydroxye-
icosatetraenoic (12-HETE), acting as a central participant
(Shim et al., 2007).
Because of their ability to cleave and thus activate
speciﬁc PARs, endogenous proteases play a speciﬁc role in
CNI. Both PAR-2 and PAR-4 are known to induce CNI and
therefore to be involved in several skin disorders, such as
pruritus and AD (Asfaha et al., 2007; Briot et al., 2009; Vel-
lani et al., 2010; Fu et al., 2014). In addition to their ability to
induce CNI via the release of SP and CGRP, it has clearly
been established that PAR-2 and PAR-4 activation could
lead to TRPV1 sensitization. Patch clamp and Ca2+ imaging
assays in HEK293 cells that co-express TRPV1 and PAR-2
and DRG neurons revealed that PAR-2 activation potenti-
ates TRPV1 via phosphorylation by PKC- and PKA-depen-
dent pathways (Amadesi et al., 2004; Dai et al., 2004;
Table 1. continued
Factors Pathways of activation References
TRPA1 Physical interaction or
iCa2+ second messenger
(Akopian et al., 2007)
(Patil et al., 2010)
Notes: a transient receptor potential vanilloid 1; b arachidonic acid; c N-arachidonoyl-dopamine ; d N-oleoyl dopamine;
e 12-hydroperoxyeicosatetraenoic acid; f 15-hydroperoxy-eicosatetraenoic acid; g leukotrien B4; h diacylglycerol; i Ca2+/
calmodulin-dependent kinase II; j phosphatidylinositol 4,5-bisphosphate; (iCa2+) intercellular Ca2+; k nerve growth factor;
l prostaglandin E2; m adenosine triphosphate; n transient receptor potential ankyrin 1; o protein phosphatase 2B; p bradykinin B2 receptor;
q G protein-coupled receptor; r receptor tyrosine kinase; s E prostanoid receptor; t protease-activated receptor-2 and 4;
u 5-hydroxytryptamine receptor; v histamine receptors 1 and 4; w purinergic P2Y1 receptor; x protein kinase C.
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Amadesi et al., 2006). As a consequence, TRPV1 sensiti-
zation by a PAR-2 agonist reduced the temperature thresh-
old for TRPV1 from 42°C to 33°C, leading to thermal
hyperalgesia, pain, and inﬂammation (Dai et al., 2004;
Amadesi et al., 2006; Amadesi et al., 2006). In addition,
PAR-2 agonists potentiated the capsaicin-evoked CGRP
and SP release from sensory neurons and thus enhanced
CNI and hyperalgesia (Hoogerwerf et al., 2001; Amadesi
et al., 2004). On the other hand, the involvement of PAR-4
activation in TRPV1 sensitization has been poorly studied.
One study demonstrated that PAR-4 activation potentiated
TRPV1 activation via a PKC-dependent pathway (Vellani
et al., 2010; Patricio et al., 2015).
Altogether, mediators released in inﬂamed skin could
contribute to peripheral sensitization, especially via TRPV1
sensitization, thus facilitating pain and itching. TRPV1 acti-
vation and/or sensitization can enhance peripheral inﬂam-
matory responses via the expression and release of other
inﬂammatory mediators.
Pro-inﬂammatory responses induced by TRPV1
activation
In addition to the clearly established role of TRPV1 in the
release of neuropeptides from sensory neurons, its ability to
increase the expression of inﬂammatory genes potentially
involved in CNI, such as those for inﬂammatory cytokines,
PGs and MMPs, has been shown in a few studies. The
activation of TRPV1 by protons led to up-regulation of the
expression of CGRP via CaMKII and CREB activation in
DRG neurons. In addition, the proton-mediated induction of
inﬂammatory pain and CGRP expression in DRG neurons
was inhibited in TRPV1-deﬁcient mice (Nakanishi et al.,
2010). Another study showed that TRPV1 activation by
capsaicin induced the PKC pathway-mediated up-regulation
of TRPV1 and CGRP expression in acute CNI and increased
PAR-4 mRNA and protein levels via a cAMP/PKA signaling
pathway in cultured primary DRG neurons (Chen et al.,
2013). Thus, it appears that a narrow interactive relationship
between PAR-4 and TRPV1 exists in the development of
NCI or in nociception from primary afferent neurons (Russell
et al., 2010; Vellani et al., 2010; Chen et al., 2013; Gouin
et al., 2015).
In addition to neuropeptide release, TRPV1-mediatedCa2+
inﬂux in the skin could induce the expression or the release of
other pro-inﬂammatory mediators and affect skin immune
cells, contributing to the self-maintenance of CNI and/or
cutaneous chronic inﬂammation.
In addition to TRPV1 activation in the sensory nerves,
TRPV1 activation in human epidermal keratinocytes by
capsaicin, acidiﬁcation or ultraviolet (UV) radiation evoked
an increase in the iCa2+ concentration (Inoue et al., 2002;
Lee et al., 2009). In fact, several studies have shown that the
exposure of keratinocytes to capsaicin or UV radiation leads
to TRPV1-mediated Ca2+ inﬂux, followed by the increased
expression of cyclo-oxygenase (COX)-2, inﬂammatory
mediators (e.g., interleukin (IL)-1β, IL-2, IL-4, and IL-8, tumor
necrosis factor (TNF)-α, PGE2, and LTB4, as well as several
MMPs, including MMP-13, 9, 3, and 2) (Inoue et al., 2002;
Southall et al., 2003; Lee et al.. 2009; Jain et al., 2011; Lee
et al., 2011). In an epithelial airway cell line, TRPV1 activa-
tion by capsaicin evoked the expression and release of
thymic stromal lymphopoietin (TSLP) via Ca2+ elevation and
calcineurin-mediated NFAT activity (Jia et al., 2014). For
keratinocytes, no relation between TSLP secretion and
TRPV1-mediated Ca2+ inﬂux has been demonstrated, and
this association needs to be investigated. Altogether, these
mediators released by keratinocytes cause erythema, pain,
and a UV-induced skin response and thickening (Lee et al.,
2009; Jain et al., 2011; Lee et al., 2011). Moreover, they are
known to sensitize TRPV1 in nociceptive neurons, with
subsequent CGRP release and CNI (Hwang et al., 2000;
Oprée and Kress 2000; Binshtok et al., 2008).
Immune cells present in the skin, such as mononuclear
cells, dendritic cells (DCs) and mast cells, also express
TRPV1, and TRPV1 activation directly affects the function of
these cells (Saunders et al., 2009; Basu and Srivastava
2005; Ständer et al., 2004). Indeed, activation of TRPV1 in
mononuclear cells induced cell death, and this response was
reversed by a TRPV1 antagonist (Saunders et al., 2009).
Capsaicin promotes DC maturation, which is abrogated in
TRPV1−/− DC cells. In an in vivo mouse model, injected
capsaicin mediated the maturation and migration of skin DCs
to the draining lymph nodes in TRPV1+/+ but not in TRPV1−/−
mice, conﬁrming an important role for this channel in the
innate immunity process (Basu and Srivastava 2005). Nev-
ertheless, the potential inﬂammatory role of TRPV1 in DCs
remains controversial, as evidenced by another study that
did not ﬁnd TRPV1 expression in DCs or the induction of
calcium elevation by capsaicin. However, the neuropeptide
SP activated DCs by eliciting robust Ca2+ elevation, sug-
gesting that DC maturation and migration are dependent on
CNI. Taken together, the potential inﬂammatory role of
TRPV1 in DCs remains unclear and needs to be investi-
gated. The involvement of mast cell degranulation during
CNI in response to capsaicin is a related process that occurs
indirectly via the release of peptide transmitters from sensory
neurons (Bunker et al., 1991; Frydas et al., 2013).
Nonetheless, TRPV1 activation by capsaicin has evoked
Ca2+ elevation in numerous mast cell lines. Capsaicin-eli-
cited Ca2+ did not induce mast cell degranulation but trig-
gered the release of IL-4 (Bı́ró et al., 1998), which is known
to be involved in AD associated with the recruitment of
neutrophils, macrophages, CD3+ lymphocytes, and epider-
mal dendritic T lymphocytes (Zhao et al., 2016).
TRPV1 is also expressed in endothelial cells and smooth
muscle cells, and its activation induces vasorelaxation by
releasing nitric oxide (NO) by a Ca2+ inﬂux-dependent
mechanism (Yang et al., 2010; Ching et al., 2011; Himi et al.,
2012). Endothelium-dependent vasodilatation is in turn
dependent on endothelial nitric oxide synthase (eNOS) and
REVIEW Olivier Gouin et al.









TRPV1, as evidenced by the inhibition of capsaicin-evoked
dilatation by an eNOS inhibitor (L-NAME) and a TRPV1
antagonist (capsazepine). These results conﬁrmed that
endothelial TRPV1 can induce vasodilatation via NO pro-
duction (Kark et al., 2008; Yang et al., 2010). In addition to
NO production, thermal endothelial-TRPV1 activation stim-
ulated the endothelial cell-derived release of CGRP from
endothelial cell lines, which contributed to the attenuation of
endothelial cell damage (Ye et al., 2007; Luo et al., 2008).
The CGRP receptor expressed on endothelial cells has been
shown to have anti-inﬂammatory effects by inhibiting the
production of the chemokines CXCL1, CCL2, and IL-8
(Huang et al., 2011). Taken together, these results indicate
that endothelial TRPV1 acts as an anti-inﬂammatory factor
both directly by inducing vasodilation via NO production and
indirectly by inhibiting leukocyte recruitment via CGRP
production.
In summary, TRPV1 activation mediates a narrow com-
munication between sensory nerve endings, skin non-im-
mune and immune cells, increasing release of inﬂammatory
mediators (mainly cytokines and neuropeptides). These
mediators act directly via speciﬁc receptors on neighboring
cells, inducing the intracellular sensitization of TRPV1 and its
activation. Hence, TRPV1 should be considered a central
modulator of the self-maintenance of CNI.
TRPA1
Another cationic channel with multiple direct roles
in neurogenic inﬂammatory dermatitis and pruritus
TRPA1 is also a nociceptive cationic (mainly Ca2+) thermo-
responsive channel that, in contrast to TRPV1, is implicated
in cold thermal sensation (i.e., temperatures below 17°C).
Besides cold stimuli, a variety of exogenous and endoge-
nous activators or sensitizers of TRPA1 have been identiﬁed
(Table 2).
The presumption that TRPA1 is involved in CNI is grow-
ing. Indeed, TRPA1 has been found to be co-expressed with
TRPV1 and neuropeptides (SP and CGRP) in a subset of
nociceptive sensory neurons (Vellani et al., 2010; Story
et al., 2003). Low temperature has been demonstrated to
activate sensory nerves and induce neurogenic inﬂammation
(Story et al., 2003; Obata et al., 2005). Indeed, TRPA1
activation stimulated (or increased) neuropeptide (SP and
CGRP) release from sensory neurons in a Ca2+-dependent
manner, with subsequent signs of CNI, such as edema and
leukocyte inﬁltration (Story et al., 2003; Meseguer et al.,
2014; Trevisani et al., 2007; Thorne et al., 1991; Silva et al.,
2011). In addition, a speciﬁc TRPA1 antagonist attenuated
the capsaicin (a TRPV1 agonist)-evoked increase of cuta-
neous blood ﬂow adjacent to an injury site in the plantar skin
of rats, strongly suggesting that both TRP channels could
cooperate in CNI induction (Wei et al., 2010).
TRPA1 is required for AD and histamine-independent
chronic itching. Indeed, in acute oxazolone-induced
dermatitis in mouse ears, TRPA1-deﬁcient mice or WT mice
treated with the TRPA1 antagonist HC-030031 showed
diminished skin inﬂammation, which was associated with a
decrease in ear epidermal thickness, eosin-positive cells,
and CD4+ and CD8+ T cells in the ear tissue. TRPA1-deﬁ-
cient mice also diminished SP- and oxazolone-evoked
scratching behavior and AD responses, as revealed by a
decrease of dermatitis score, including erythema, scaring,
excoriation, and swelling (Liu et al., 2013). Histamine-inde-
pendent pruritus evoked by the TRPA1 agonists chloroquine,
BAM8–22 or AEW was abrogated in neurons from TRPA1-
deﬁcient mice, impairing the scratching behavior response
and increasing epidermal thickness (Wilson et al., 2011;
Wilson et al., 2013a). In addition, the inﬂammatory cytokine
TSLP is highly expressed in skin epithelial cells from AD
patients and induces (or enhances) skin inﬂammation via T
cells, DCs, and mast cell activation (Ziegler et al., 2013;
Moniaga et al., 2013). Within the skin, TSLP also activates
sensory neurons via TSLPR, and, subsequently, TRPA1
stimulation via a PLC-mediated pathway, thereby evoking
robust itching in mice (Wilson et al., 2013b). To date, there is
no evidence that TSLP and TRPA1 can induce CNI by
releasing neuropeptides.
Similar to TRPV1, TRPA1 is also under the control of an
intracellular sensitization process involving several inﬂam-
matory mediators, such as growth factors, bradykinins, pro-
teases, and cytokines. By its localization in neuronal and
non-neuronal skin cells, TRPA1 potentiates neurogenic skin
inﬂammation by enhancing cellular responses (Inoue et al.,
2002; Bautista et al., 2013).
TRPA1 sensitization/desensitization by endogenous
modulators following intracellular pathway activation
In a manner similar to that of TRPV1, TRPA1 activity is
controlled by desensitization and sensitization processes.
The repeated activation of TRPA1 by chemical stimuli results
in the Ca2+- and current-dependent desensitization of
TRPA1 (Story et al., 2003; Malin et al., 2011; Wilson and
Bautista 2014). TRPA1 is a polymodal receptor with multiple
intracellular ligand binding and phosphorylation sites that are
involved in the activation and sensitization of this channel,
respectively. Unlike most TRP channels, TRPA1 covalently
interacts with many of its agonists through its N-terminal
region, which contains cysteine and lysine residues involved
in its direct activation (Hinman et al., 2006; Macpherson
et al., 2007). Direct mechanisms of TRPA1 activation have
been described, although the precise mechanisms of sen-
sitization/desensitization by which the inﬂammatory media-
tors potentiate the channel activity remain poorly
understood. Recent data, using cryo-EM, provided for the
ﬁrst time the structure of TRPA1 and shown several simi-
larities with TRPV1 (Paulsen et al., 2015). It is appeared that
the NH2-terminal of TRPA1 has approximately 15 ankyrin
repeats with several cysteine and lysine residues crucial for
activation by reactive agonists (Hinman et al., 2006;
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Table 2. Endogenous and exogenous agonists involved in TRPA1 activation, sensitization, and inhibition
Factors Pathways of activation References
Exogenous activators of TRPA1a:
















Clove bud oil compounds:
-Eugenol
THCc
(Calixto et al., 2005)
(Macpherson et al., 2005)




(Bautista et al., 2006)









(Imamachi et al., 2009)
(Mishra and Hoon 2010)
(Mishra et al., 2011)
(Wilson et al., 2011, 2013a, b)












(Pertovaara and Koivisto 2011)




(Taylor-Clark et al., 2009)
(Engel et al., 2011)
DAGn (Trevisani et al., 2007)
(Bandell et al., 2004)
(Jordt et al., 2004)
Indirect activators/sensitizers of TRPA1:
Bradykinin BK2Rt (GPCRu) (Bandell et al., 2004)
(Wang et al., 2008a)
Growth factors (e.g., NGFo and BDNFp) RTKv (Malin et al., 2011)
Proteases PAR-2 and PAR-4w (GPCR) (Dai et al., 2007)
(Patricio et al., 2015)
Low iCa2+ concentration EF-hand Ca2+-binding domain (Sura et al., 2012)
(Akopian et al., 2007)
Cytokines (e.g., TSLPq) TSLP receptor (RTK) (Wilson et al., 2013a, b)
TRPV1r Physical interaction or
Ca2+ second messenger
(Honda et al., 2014)
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Macpherson et al., 2007). A EF-hand domain implicated in
calcium-dependent gating was also found in its NH2 region
(Zurborg et al., 2007; Doerner et al., 2007). Other speciﬁc
domains have also been described such as a PIP2 binding
site as well as CAMKII and PKC phosphorisation site (Choi
et al., 2014). The transmembrane domain S6 are essential
for gating by antagonists and agonists (Chen et al., 2008).
iCa2+ potentiates TRPA1 activation
Growing evidence suggests that Ca2+ regulates TRPA1 by
potentializing and inactivating its activity at low and high
intracellular concentrations, respectively (Jordt et al., 2004;
Doerner et al., 2007). On the one hand, Ca2+ potentiated
cinnamaldehyde-, AITC-, and carvacrol-evoked currents in
HEK293 cells expressing TRPA1. In addition, an increase in
iCa2+ also seems to directly act on the activation of TRPA1
by eliciting a current in a PLC-independent manner and
serves as a co-agonist with icilin that directly interacts with
TRPA1 (Zurborg et al., 2007; Doerner et al., 2007; Wang
et al., 2008b). On the other hand, Ca2+ could also inactivate
TRPA1. Indeed, even though high extracellular Ca2+ con-
centrations could enhance a cinnamaldehyde-evoked cur-
rent, they could also induce rapid inactivation, which has not
been found at low extracellular Ca2+ concentrations (Wang
et al., 2008b). Hence, Ca2+ appears to be a crucial factor for
the regulation of TRPA1 activity, suggesting that other TRP
channels and GPCRs could modulate TRPA1 activity by
mobilizing iCa2+.
Intracellular sensitizers of TRPA1
Several studies suggest that TRP channels may be poten-
tiated by endogenous DAG and IP3, the products of PIP2
breakdown, by Ca2+ release from internal stores, by PKC
activation or by the formation of endogenous lipid oxidation-
derived and products in sensory neurons (Wang et al.,
2008a; Mizumura et al., 2009). TRPA1-expressing CHO
cells were also sensitive to DAG, arachidonic acid, and iCa2+
(Jordt et al., 2004; Bandell et al., 2004). PIP2 has an inhi-
bitory effect not only on TRPV1 activity (refer to section In-
tracellular pathways of TRPV1 sensitization) but also on
TRPA1 activity, since PIP2 has been shown to inhibit AITC-
and mustard oil-evoked currents (Kim et al., 2008; Kara-
shima et al., 2008). Moreover, the reduction of the PIP2 level
at the membrane by polyphosphatase (e.g., PPPi), PIP2
antibody or phenylarsine oxide enhanced the AITC- and
mustard oil-evoked currents via TRPA1 sensitization (Kim
et al., 2008; Karashima et al., 2008). Taken together, these
data suggest that TRPA1 activity could be sensitized by the
activation of numerous GPCRs or receptor tyrosine kinases
(RTKs) via the cAMP/PKA and PLC/PKC pathways following
Ca2+ elevation (Taylor-Clark et al., 2008; Andersson et al.,
2008; Taylor-Clark et al., 2009)
TRPA1 sensitization by inﬂammatory mediators
Several inﬂammatory mediators, such as growth factors,
bradykinins, proteases, and, more recently, the inﬂammatory
cytokine TSLP, have been found to act indirectly on TRPA1
activity and expression through speciﬁc receptor-dependent
signaling pathways (Diogenes et al., 2007; Dai et al., 2007;
Wang et al., 2008a; Malin et al., 2011). It has now been
clearly established that TRPA1 in sensory neurons mediates
the CNI responses to bradykinin (Jordt et al., 2004; Bandell
et al., 2004; Bautista et al., 2006; Wang et al., 2008a), NGF,
and brain-derived neurotrophic factor (BDNF) (Malin et al.,
2011) by potentiating the activity of the channel and impair-
ing its desensitization after repeated activation. In addition,
NGF has been found to up-regulate the expression of
TRPA1 mRNA via p38 MAPK activation in trigeminal ganglia
and sensory neurons. Taken together, these mediators
enhance the activity and prevent the desensitization of
TRPA1 and consequently facilitate pain, hyperalgesia, and
allodynia (Obata et al., 2005; Diogenes et al., 2007). TSLP
Table 2. continued
Factors Pathways of activation References
Inhibitors/desensitizers of TRPA1:
High iCa2+ concentration EF-hand Ca2+-binding domain (Sura et al., 2012)
(Wang et al., 2008b)
PIP2s Direct binding to TRPA1 (Karashima et al., 2008)
(Kim et al., 2008)
TRPV1 Physical interaction or
Ca2+ second messenger
(Akopian et al., 2007)
(Staruschenko et al., 2010)
(Salas et al., 2009)
Notes: a transient receptor potential ankyrin 1; b allyl isothiocyanate; c tetrahydrocannabinol; d transient receptor potential melastatin 8;
e bovine adrenal medulla 8-22; f acetone, ether and water; g reactive oxygen species; h nitric oxide; i prostaglandin A2;
j 15-deoxy-delta12,14-prostaglandin J2; k Δ12-prostaglandin J2; l 4-hydroxynonenal; m 4-oxo-2-nonenal; n diacylglycerol;
o nerve growth factor; p brain-derived neurotrophic factor; q thymic stromal lymphopoietin; r transient receptor potential vanilloide 1;
s phosphatidylinositol 4,5-bisphosphate; t bradykinin B2 receptor; u G protein-coupled receptor; v receptor tyrosine kinase;
w protease-activated receptor-2 and 4.
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released from keratinocytes potentiated TRPA1 activity by
binding to its speciﬁc receptor (TSLPR) on sensory neurons
in the skin of AD patients and in mouse models of AD. While
TSLP-evoked sensory neuron activation and consequent
chronic itching in AD has been established, the role of TSLP-
triggered neuropeptide release in neurons and the subse-
quent CNI remain an open question (Wilson et al., 2013a, b).
While the involvement of endogenous proteases in
TRPV1 sensitization via PAR-2 and PAR-4 activation is well
established (refer to section Inﬂammatory mediators that use
TRPV1 intracellular sensitization pathways), the implication
of these proteases in TRPA1 sensitization remains poorly
understood. PAR2 activation has been demonstrated to
enhance TRPA1 agonist-evoked pain behavior in rats via
PLC activation and subsequent PIP2 hydrolysis (Dai et al.,
2007). In addition, PAR-2-evoked mechanical and cold
allodynia, as well as heat hyperalgesia, was found to be
dependent on the PKA and PKC signaling pathways, which
sensitize TRPA1 (Chen et al., 2011). The involvement of
PAR-4 in the sensitization of TRPA1 is poorly studied, but a
recent ﬁnding demonstrated its potential role in pruritus: the
dorsal intradermal administration of the PAR-4 agonist pep-
tide AYPGKF-NH2 elicited intense scratching behavior via a
SP release in mice, which was abolished by the TRPV1 and
TRPA1 antagonists SB366791 and HC-030031, respectively
(Patricio et al., 2015), but not in TRPA1-deﬁcient mice. An
opposite pattern in PAR-4-evoked itching via TRPA1 by
compensatory mechanisms in TRPA1− deﬁcient mice has
been hypothesized (Patricio et al., 2015; Petrus et al., 2007).
Consequently, PAR-4 activation could sensitize TRPA1 in
collaboration with TRPV1 and elicit itching behavior via the
release of neuropeptides from sensory neurons; however,
some points still require clariﬁcation, mainly the intracellular
pathways underlying the TRPV1/TRPA1 sensitization via
PAR-4 activation (Patricio et al., 2015).
Finally, the intracellular pathways for many inﬂammatory
mediators could sensitize TRPA1 in injured skin, contributing
to channel activity and impairing the TRPA1 desensitization,
thereby enhancing peripheral inﬂammatory responses via
the production of other inﬂammatory mediators.
A pro-inﬂammatory response induced by TRPA1
activation
In addition to its ability to induce the release of neuropep-
tides from sensory neurons, TRPA1 seems to play an
important role in the modulation of numerous genes that
could amplify the cutaneous inﬂammatory process. The
involvement of TRPA1 in the regulation of 1,843 (2,423
probe sets) genes in whole trigeminal ganglia isolated from
AEW-treated mice has been established (Wilson et al.,
2013a). In this model, TRPA1 activation by AEW highly up-
or down-regulated the expression of several cytokines,
plasmatic receptors, and ion channels and affected growth
regulation, intracellular pathways, and immune cell speci-
ﬁcity proteins. For example, AEW up-regulated the
inﬂammatory bradykinin receptor (BK2R) by 2-fold and up-
regulated several itch receptors such as MRGPR and PAR-2
in the trigeminal ganglia neurons (Wilson et al., 2013a).
These three receptors sensitize and open TRPA1. Thus, the
up-regulation of itch and inﬂammatory receptors in sensory
neurons strongly indicates a role for TRPA1 in chronic pru-
ritus and CNI via the enhancement of sensory neuron sen-
sitivity to itch and inﬂammatory mediators.
Growing evidence indicates that TRPA1 acts as an
inﬂammatory regulator. The results of recent studies corre-
lated the activation of TRPA1 with expressional changes in
the skin, as associated with cutaneous inﬂammation, AD,
and pain that is blocked in TRPA1-deﬁcient mice. Indeed,
TRPA1 activation by oxazolone induced chronic dermatitis in
mouse ears and concomitant up-regulation of inﬂammatory
cytokines (i.e., IL-1β, IL-4, and IL-16 and chemokine (C-X-C
motif) ligand 2 (CXCL-2)), neuropeptides (i.e., SP and
endothelin (ET-1)), nerve growth factor (NGF), and neuro-
transmitters (i.e., serotonin) known to induce AD, pruritus,
and pain and increase nerve ﬁber density (Liu et al., 2013).
Additional studies established the expressional change of
9,340 genes linked to itching associated with TRPA1 in skin
biopsies from AEW-treated mice, showing that TRPA1 up-
regulated the expression of 79% of itch-related genes known
to be involved in the initiation and maintenance of chronic
itching as well as pruriginous skin disorders (e.g., the IL-31
receptor (IL-31RA), aquaporin 3, and IL-33 (Wilson et al.,
2013a; Nakahigashi et al., 2011; Nobbe et al., 2012; Olsson
et al., 2006; Sonkoly et al., 2006). In these studies, the
expressional changes induced by oxazolone or AEW were
abrogated in the TRPA1−/− mice and in WT mice treated with
TRPA1 antagonists (Wilson et al., 2013a; Liu et al., 2013).
These data strongly suggest the involvement of TRPA1 in
pruritus.
TRPA1 is also expressed in the basal keratinocytes,
where it acts as a pain, thermal, and chemical sensor (Ato-
yan et al., 2009). TRPA1 was found to modulate inﬂamma-
tory gene expression in keratinocytes by increasing the
expression of IL-1α and IL-1β (Atoyan et al., 2009) and
cause the secretion of PgE2 (Jain et al., 2011). Both IL-1 and
PgE2 are known to be involved in skin inﬂammation and
itching by decreasing the mechanical threshold and the
thermal responsiveness of the sensory nerve endings, which
could facilitate CNI (Binshtok et al., 2008). In addition, in
keratinocytes, TRPA1 activation increases heat shock pro-
tein (HSP) 27, which is known to up-regulate the expression
of inﬂammatory cytokines such as IL-1β, TNF-α, and IL-6 in
the skin during murine allergic contact hypersensitivity
(Yusuf et al., 2009; Atoyan et al., 2009). Altogether, these
ﬁndings indicate that TRPA1 activation contributes to the
production of several cytokines from keratinocytes that
directly trigger or enhance CNI by acting on neighboring
target cells.
In addition to keratinocytes, TRPA1 acts on skin immune
cells, but it appears to have an anti-inﬂammatory role in mono-
cytes/macrophages. The TRPA1 activators cinnamaldehyde
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and carvacol have been found to inhibit bacterial lipopolysac-
charides (LPS)-induced nuclear factor-kappa B (NF-κB)-medi-
ated promoter activity and reduce the expression of iNOS,
COX2, and TNF-α and subsequent NO production in macro-
phages (Chao et al., 2008; Romano et al., 2013). Similarly,
cinnamaldehyde inhibited bacterial LPS- and lipoteichoic acid
(LTA)-mediated IL-1β, IL-6, and TNF-α release in murine mac-
rophages and human blood monocytes, presumably through
ROS production (Hsu and Wen 2002; Chao et al., 2008;
Romanoetal., 2013). Furthermore, an increase inTNF-αaswell
as the induction of both kinnitric oxide synthases (iNOS) and
COX2, which are involved in the formation of NO and PGE2,
respectively, are known to act in the pathogenesis of several
inﬂammatory skin diseases, such as AD, psoriasis, and pruritus
(Ormerod et al., 1998; Kim et al., 2015; Ostadhadi et al., 2015;
Ahn et al., 2016; Sereﬂican et al., 2016). It would therefore
appear that TRPA1 acts as an anti-inﬂammatory actor in
monocytes and macrophages, but these data are controversial
(Billeter et al., 2015). The activation of TRPA1 by cinnamalde-
hyde acts on adaptive immunity by suppressing lymphoprolif-
eration and promoting T-cell maturation, as revealed by T-cell
differentiation from CD4 and CD8 double-positive cells to CD4
or CD8 single-positive cells in LPS-treated mouse splenocytes
(Koh et al., 1998). These results imply that TRPA1 could
enhance inﬂammation and immunoreactivity by directly acting
on lymphocyte differentiation.
TRPA1 activation by AITC has been found to trigger
vasodilatation in rat cerebral arteries in an endothelium-de-
pendent mechanism. TRPA1-mediated vasodilation triggers
Ca2+ inﬂux in rat endothelial arteries through Ca2+-activated
potassium channels in endothelial cells and inwardly recti-
fying potassium channels in arterial myocytes (Earley et al.,
2009; Qian et al., 2013). This mechanism suggests that this
channel could also act in edema and vasodilatation during
CNI, but this hypothesis must be veriﬁed. However, another
study established that TRPA1 activation by cinnamaldehyde
played an anti-inﬂammatory role by suppressing the attach-
ment of leukocytes to endothelial cells (Liao et al., 2008).
To conclude, TRPA1 activation and sensitization mediate
skin inﬂammation by increasing the release of inﬂammatory
mediators, although their role in immune cells remains to be
clariﬁed. In turn, secreted factors mediate the intracellular
sensitization of TRPA1, thus facilitating its activation, which
in turn contributes to enhancement of the self-maintenance
of CNI.
CROSS-REGULATION BETWEEN TRPV1 AND
TRPA1
In addition to co-expression in a subset of sensory nerves
and non-neuronal cells (keratinocytes), a functional interac-
tion between TRPA1 and TRPV1 (cross-sensitization/de-
sensitization) has been established, which suggests the
cooperation between these channels to promote inﬂamma-
tory thermal hyperalgesia, CNI, and pain (Bautista et al.,
2006; Akopian et al., 2007; Anand et al., 2008; Patil et al.,
2010; Aubdool and Brain 2011; Spahn et al., 2014; Fischer
et al., 2014).
This cross-communication between TRPA1 and TRPV1
appears to involve the concentration of cytosolic Ca2+, one
of the main sensitizers/desensitizers of TRPA1 and TRPV1
(Jordt et al., 2004; Jung et al., 2004; Doerner et al., 2007;
Woo et al., 2008). It has been shown that capsaicin- and
mustard oil-evoked currents desensitized each other via
iCa2+ elevation in TRPV1- and/or TRPA1-expressing CHO
cells (Akopian et al., 2007). Another relevant study con-
ﬁrmed the role of the inﬂux of Ca2+ via TRPV1 as a second
messenger for the desensitization of TRPA1. Indeed, TRPA1
evoked a current in CHO cells expressing TRPA1, and this
current was inhibited by the co-expression of TRPV1 (Patil
et al., 2010). In addition, TRPA1 and TRPV1 were found to
interact by forming a physical and functional interaction at
the plasma membrane, as revealed by co-IP and FRET
assays in TRPA1- and TRPV1-co-expressing CHO cells, as
well as in sensory neurons (Akopian et al., 2007; Salas et al.,
2009; Staruschenko et al., 2010; Fischer et al., 2014). In
these cells, TRPV1 regulated the desensitization of TRPA1,
which appeared to be independent of iCa2+ (Staruschenko
et al., 2010).
On the other hand, evidence has established that the
TRPV1 and TRPA1 channels also sensitize each other in a
Ca2+-dependent signaling pathway. Indeed, bradykinin and
facial capsaicin injections sensitized TRPA1 via TRPV1 in a
Ca2+-dependent manner in cultured trigeminal neurons from
mice and rats, leading to inﬂammatory cold hyperalgesia
(Bautista et al., 2006; Honda et al., 2014). The opposite
pattern was also found: TRPA1 could sensitize TRPV1 to
AITC-, cinnamaldehyde-, and mustard oil-enhanced heat-
and capsaicin-evoked currents and Ca2+ elevation in a
Ca2+-, cAMP/PKA-, and TRPV1 phosphorylation-dependent
manner in sensory neurons and in HEK293 cells co-ex-
pressing TRPV1 and TRPA1 (Anand et al., 2008; Alpizar
et al., 2013; Spahn et al., 2014).
Altogether, the TRPV1-TRPA1 interaction and cross-
communication via the iCa2+ concentration could inhibit or
enhance the ability to a large variety of exogenous and
endogenous activators to cause Ca2+ elevation, neuropep-
tide release and, consequently, CNI.
CONCLUSIONS AND FUTURE DIRECTIONS
The TRPV1 and TRPA1 channels are at the core of the
inﬂammatory process that occurs in various cutaneous
neurogenic disorders that are pruritic diseases, such as
psoriasis, AD, and Netherton syndrome. It is now clear that
both TRP channels act far beyond the sensory nerves by
potentiating the pathology of numerous skin disorders in
non-neuronal skin cells, such as keratinocytes, mast cells,
dendritic cells, and blood vessels. We still have a great deal
to learn about these channels, notably about the change of
gene expression in sensory neurons and non-neuronal skin
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cells, especially in relation to their role in the induction and
self-maintenance of CNI (in vitro and in vivo). A great deal of
knowledge about their interaction, their cross-sensitization,
and their sensitization by inﬂammatory mediators awaits
discovery, especially in relation to the potentiation and the
chronicitization of skin disorders associated with CNI.
Although the molecular mechanisms of TRPV1 and TRPA1
sensitization induced during CNI and itching are still poorly
understood, their clinical relevance in pruritus, inﬂammatory
thermal hyperalgesia, and pain are indisputable.
Targeting one or more of the intracellular signaling path-
ways of TRP channel sensitization may allow new opportu-
nities for the treatment of skin disorders associated with CNI.
Further studies are necessary to test the potential effects of
treatment with protein signaling inhibitors in neurogenic
inﬂamed skin. A new and interesting approach could also be
to focus on the effect of the iCa2+ concentration to mediate
TRP desensitization and thus block the self-maintenance of
CNI.
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